Mayo Dialysis - Wabasha in Wabasha, Minnesota - Dialysis Center

Mayo Dialysis - Wabasha is a medicare approved dialysis facility center in Wabasha, Minnesota and it has 6 dialysis stations. It is located in Wabasha county at 1200 5th Grant Blvd W, Wabasha, MN, 55981. You can reach out to the office of Mayo Dialysis - Wabasha at (651) 565-5995. This dialysis clinic is managed and/or owned by Mayo Clinic Dialysis. Mayo Dialysis - Wabasha has the following ownership type - Non-Profit. It was first certified by medicare in May, 1992. The medicare id for this facility is 243515 and it accepts patients under medicare ESRD program.

Name	Mayo Dialysis - Wabasha
Location	1200 5th Grant Blvd W, Wabasha, Minnesota
No. of Dialysis Stations	6
Medicare ID	243515
Managed By	Mayo Clinic Dialysis
Ownership Type	Non-Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Mayo Dialysis - Wabasha from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data

10

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	17
  Adult patient months included in Kt/V greater than or equal to 1.2	149
  Percentage of adult patients getting regular hemodialysis at the center	95
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Mayo Dialysis - Wabasha with elevated calcium levels.

Patients with hypercalcemia	17
Hypercalcemia patient months	149
Patients with Serumphosphor	18
Patients with Serumphosphor less than 3.5 mg/dL	12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	30
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	35
Patients with Serumphosphor from 5.6 to 7 mg/dL	17
Patients with Serumphosphor greater than 7 mg/dL	6

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	16
Patient months included in arterial venous fistula and catheter summaries	128
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	66
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	21

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	10
Hospitalization Rate in facility	140.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit	459.7
Hospitalization Rate: Lower Confidence Limit	47.4